Is Nuvalent, Inc. (NUVL) a Buy, Sell, or Hold?
NASDAQ : NUVL
Nuvalent, Inc. — Institutional Ownership
$123.96 USD
$0 (0.0%)
- Volume
- 0
- Average Volume
- 2.33M
- Market Capitalization
- $9.13B
- P/E Ratio
- -20.46
- Dividend Yield
- 0.00%
- Price Target
- $124.00
- Year High
- $123.99
- Year Low
- $71.13
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $16.14
Institutional Ownership Summary
Institutional Ownership %
0.76%
Investors Holding
50
change: -219 | last: 269
Increased Positions
27
change: -137 | last: 164
Reduced Positions
13
change: -56 | last: 69
New Positions
16
change: -39 | last: 55
Sold Positions
230
change: 200 | last: 30
Total Calls
-
Total Puts
3500
Put-Call Ratio
0.00
change: -77.4468 | last: 0.7745
Total Invested
70.82M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-06 | FMR LLC | 9.25M | 12.60% |
| 2026-03-27 | The Vanguard Group | - | 0.00% |
| 2026-02-12 | Deerfield Management Company, L.P. | 22.85M | 24.21% |
| 2025-07-17 | BlackRock, Inc. | 3.34M | 5.00% |
| 2025-04-28 | BlackRock, Inc. | 2.95M | 4.50% |
| 2025-02-13 | Deerfield Management Company, L.P. | 23.58M | 27.59% |
| 2025-01-31 | The Vanguard Group | 4.5M | 6.85% |
| 2024-11-08 | (1) BlackRock, Inc. | 3.62M | 5.60% |
| 2024-10-24 | (1) BlackRock, Inc. | 3.62M | 5.60% |
| 2024-02-13 | The Vanguard Group - 23-1945930 | 3.34M | 5.72% |
| 2024-01-02 | Joseph Edelman | 2.92M | 5.10% |
| 2024-01-02 | Perceptive Advisors LLC | 2.92M | 5.10% |
| 2024-01-02 | Perceptive Life Sciences Master Fund, Ltd. | 2.92M | 5.10% |
| 2022-11-14 | Deerfield Healthcare Innovations Fund, L.P. | 12.39M | 18.96% |
| 2022-11-14 | Deerfield Mgmt IV, L.P. | 12.39M | 18.96% |
| 2022-11-14 | Deerfield Private Design Fund IV, L.P. | 12.39M | 18.96% |
| 2022-11-14 | Deerfield Mgmt HIF, L.P. | 12.39M | 18.96% |
| 2022-11-14 | Deerfield Mgmt, L.P. | 650K | 1.27% |
| 2022-11-14 | James E. Flynn | 25.47M | 39.24% |
| 2022-11-14 | Deerfield Management Company, L.P. | 25.47M | 39.24% |
| 2022-11-14 | Deerfield Partners, L.P. | 650K | 1.27% |
| 2022-11-09 | Tomas Kiselak | 2.61M | 5.13% |
| 2022-11-09 | Fairmount Funds Management LLC | 2.61M | 5.13% |
| 2022-11-09 | Peter Harwin | 2.61M | 5.13% |
| 2022-11-09 | Fairmount Healthcare Fund II L.P. | 2.52M | 4.97% |
| 2022-02-11 | Deerfield Mgmt HIF, L.P. | 12.39M | 22.57% |
| 2022-02-11 | Deerfield Healthcare Innovations Fund, L.P. | 12.39M | 22.57% |
| 2022-02-11 | Deerfield Private Design Fund IV, L.P. | 12.39M | 22.57% |
| 2022-02-11 | Deerfield Mgmt IV, L.P. | 12.39M | 22.57% |
| 2022-02-11 | James E. Flynn | 24.78M | 45.14% |
| 2022-02-11 | Deerfield Management Company, L.P. | 24.78M | 45.14% |
| 2021-08-10 | Abigail P. Johnson | 4.7M | 11.42% |
| 2021-08-10 | FMR LLC | 4.7M | 11.42% |
| 2021-08-04 | BCLS II Investco, LP | 735K | 1.70% |
| 2021-08-04 | BCIP Life Sciences Associates, LP | 292.38K | 0.70% |
| 2021-08-04 | Bain Capital Life Sciences Fund II, L.P. | 2.4M | 5.60% |
NUVL Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $100.59 | 72.69M | $7.31B | $261.74M | -$ | $7.05B |
| 2024-12-31 | $78.28 | 66.41M | $5.2B | $145.69M | -$ | $5.05B |
| 2023-12-31 | $73.59 | 58.22M | $4.28B | $335.39M | -$ | $3.95B |
| 2022-12-31 | $29.78 | 49.67M | $1.48B | $241.81M | -$ | $1.24B |
| 2021-12-31 | $19.04 | 21.78M | $414.75M | $68.53M | -$ | $346.22M |
| 2020-12-31 | $18.75 | 22.86M | $428.7M | $10.33M | $2.24M | $420.6M |
| 2019-12-31 | $18.75 | 48.28M | $905.32M | $3.02M | $2.17M | $904.48M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $102.45 | 78.67M | $8.06B | $159.73M | -$ | $7.9B |
| 2025-12-31 | $100.59 | 75.12M | $7.56B | $261.74M | -$ | $7.29B |
| 2025-09-30 | $86.48 | 72.14M | $6.24B | $115.75M | -$ | $6.12B |
| 2025-06-30 | $76.30 | 71.84M | $5.48B | $127.47M | -$ | $5.35B |
| 2025-03-31 | $70.92 | 71.61M | $5.08B | $120.84M | -$ | $4.96B |
| 2024-12-31 | $78.28 | 71.16M | $5.57B | $145.69M | -$ | $5.42B |
| 2024-09-30 | $102.30 | 65.68M | $6.72B | $369.24M | -$ | $6.35B |
| 2024-06-30 | $75.51 | 64.6M | $4.88B | $77.7M | -$ | $4.8B |
| 2024-03-31 | $77.09 | 64.15M | $4.95B | $98.52M | -$ | $4.85B |
| 2023-12-31 | $73.59 | 62.18M | $4.58B | $335.39M | -$ | $4.24B |
| 2023-09-30 | $45.97 | 57.09M | $2.62B | $88.43M | -$ | $2.54B |
| 2023-06-30 | $42.17 | 56.87M | $2.4B | $70.87M | -$ | $2.33B |